BlackRock Institutional Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

BlackRock Institutional Trust’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$493K	Hold	469,440	–	–	﹤0.01%	3463
2016 Q3	$512K	Hold	469,440	–	–	﹤0.01%	3480
2016 Q2	$333K	Sell	469,440 -621,162	-57%	-$500K	﹤0.01%	3567
2016 Q1	$1.28M	Sell	1,090,602 -21,148	-2%	-$32.8K	﹤0.01%	3218
2015 Q4	$2.72M	Buy	1,111,750 +30,918	+3%	+$88.6K	﹤0.01%	2992
2015 Q3	$3.24M	Buy	1,080,832 +363,678	+51%	+$1.57M	﹤0.01%	2913
2015 Q2	$2.96M	Buy	717,154 +566,044	+375%	+$2.26M	﹤0.01%	2963
2015 Q1	$654K	Buy	151,110 +119,870	+384%	+$432K	﹤0.01%	3453
2014 Q4	$93K	Buy	31,240 +26,458	+553%	+$72.6K	﹤0.01%	3716
2014 Q3	$16K	Buy	+4,782	New	+$12.5K	﹤0.01%	3780

Other funds holding CPRX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

TCM

Tanaka Capital Management New York $59.9M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BlackRock Institutional Trust's CPRX Position: Q4 2016 in Review

BlackRock Institutional Trust held its Catalyst Pharmaceutical (CPRX) position steady in Q4 2016 at 469,440 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #3463.

BlackRock Institutional Trust first reported a position in CPRX in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.24M in Q3 2015. 54 funds tracked by Wall St. Rank hold CPRX as of Q4 2016.

BlackRock Institutional Trust held 469,440 shares of Catalyst Pharmaceutical worth $493K as of Q4 2016.
BlackRock Institutional Trust left its Catalyst Pharmaceutical share count unchanged in Q4 2016.
Catalyst Pharmaceutical made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3463 holding.
BlackRock Institutional Trust first reported a position in Catalyst Pharmaceutical in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Catalyst Pharmaceutical position peaked at $3.24M in Q3 2015.
54 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.